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Background: Pathogenic chlamydiae are obligate intracellular pathogens and have adapted successfully to human
cells, causing sexually transmitted diseases or pneumonia. Chlamydial outer protein N (CopN) is likely a critical
effector protein secreted by the type III secretion system in chlamydiae, which manipulates host cells. However, the
mechanisms of its action remain to be clarified. In this work, we aimed to identify previously unidentified CopN effector
target in host cells.
Results: We first performed a pull-down assay with recombinant glutathione S-transferase (GST) fusion CopN proteins
(GST–CpCopN: Chlamydia pneumoniae TW183, GST–CtCopN: Chlamydia trachomatis D/UW-3/CX) as “bait” and soluble
lysates obtained from human immortal epithelial HEp-2 cells as “prey”, followed by SDS-PAGE with mass spectroscopy
(MS). We found that a host cell protein specifically bound to GST–CpCopN, but not GST–CtCopN. MS revealed the
host protein to be fructose bisphosphate aldolase A (aldolase A), which plays a key role in glycolytic metabolism.
We also confirmed the role of aldolase A in chlamydia-infected HEp-2 cells by using two distinct experiments for gene
knockdown with an siRNA specific to aldolase A transcripts, and for assessment of glycolytic enzyme gene expression
levels. As a result, both the numbers of chlamydial inclusion-forming units and RpoD transcripts were increased in the
chlamydia-infected aldolase A knockdown cells, as compared with the wild-type HEp-2 cells. Meanwhile, chlamydial
infection tended to enhance expression of aldolase A.
Conclusions: We discovered that one of the C. pneumoniae CopN targets is the glycolytic enzyme aldolase A.
Sequestering aldolase A may be beneficial to bacterial growth in infected host cells.
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Obligate intracellular pathogens Chlamydia pneumoniae
and Chlamydia trachomatis are major clinical and pub-
lic health concerns, and cause pneumonia [1,2] and the
most prevalent sexually transmitted diseases worldwide
[3,4], respectively. Although C. pneumoniae is also associ-
ated with chronic inflammatory diseases such as asthma
[5] and atherosclerosis [2], its etiological role remains to
be clarified.
Chlamydiae undergo a unique biphasic developmental
cycle, with a morphological change between the elemen-
tal body (EB), which is an infectious form, and reticulate* Correspondence: hiroyuki@med.hokudai.ac.jp
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unless otherwise stated.body (RB), which is a replicative form, into the sur-
rounding plasma membrane, the so-called inclusion
membrane [6-8]. To complete their developmental cycle,
chlamydiae utilize the type III secretion system (T3SS)
to translocate several effector proteins across the inclu-
sion membrane [9]. Accumulating evidence from experi-
ments with Shigella or Salmonella have shown that
T3SS effectors play a critical role in bacterial invasion and
maturation, and maintenance of host cell viability, which
is directly related to bacterial pathogenesis [10,11]. Al-
though several chlamydial T3SS effectors such as translo-
cated actin recruiting phosphoprotein (TARP) [12],
inclusion membrane protein A (IncA) [13], and chlamyd-
ial outer protein N (CopN) [14] have been documented,
mechanisms of host cell manipulation evoked by these ef-
fectors remain to be clarified.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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proteins including tip, needle, rod and plug proteins,
and ATPase [15], and the effector proteins translocating
across the plasma membrane are strictly regulated by
the plug proteins. For instance, MxiC, a plug protein of
Shigella flexneri, regulates effector secretion [16,17]. The
activation of Yersinia T3SS effector secretion is con-
trolled by YopN/TyeA as a plug complex of Yersinia
T3SS in response to extracellular calcium and/or contact
with eukaryotic cells [18,19]. Also, translocation of some
plug proteins such as YopN or MxiC into eukaryotic host
cells has been documented [16,20]. Thus, these bacterial
plug molecules, possibly with effector function, have a
central role into controlling T3SS effector secretion.
Recent work has shown that chlamydial CopN, which
is homologous to YopN and MxiC but with low similar-
ity, is a T3SS plug protein, and is secreted by a Yersinia
type III apparatus [14,21,22]. Also, CopN domain struc-
ture analysis using gel filtration assay with His-tagged re-
combinant proteins has revealed that CopN binds to
tubulin, which prevents microtubule assembly [23]. Fur-
thermore, yeast two-hybrid analysis has shown the essen-
tial role of the CopN effector protein in C. pneumoniae
intracellular growth [24]. Thus, these findings support that
chlamydial CopN has a critical role as a T3SS plug with ef-
fector function in the chlamydial host manipulation sys-
tem. Whether the CopN targets tubulin alone remains to
be determined.
Here, we showed that C. pneumoniae CopN interacted
with a glycolytic enzyme, fructose bisphosphate aldolase
A (aldolase A). Our data also suggested that sequestering




The immortal human epithelial cell lines HEp-2 and HeLa
were purchased from American Type Culture Collection
(Manassas, VA, USA) and Riken Cell Bank (Tsukuba,
Japan), respectively. Both the cell lines were cultured
at 37°C in 5% CO2 in Dulbecco’s Modified Eagle’s
Medium (DMEM; Sigma, St. Louis, MO, USA) containing
10% heat-inactivated fetal calf serum (FCS), and antibi-
otics [10-μg/ml gentamicin, 10-μg/ml vancomycin and
0.5-μg/ml amphotericin B (Sigma)] (GVA antibiotics)
[25,26].
Chlamydiae and growth conditions
C. pneumoniae TW183 strain was kindly provided by
G. Byrne, University of Tennessee (Memphis). C. tracho-
matis D/UW3 CX strain (VR-885) was purchased from
ATCC. Chlamydiae were propagated in HEp-2 and HeLa
cells, as described previously [25,26]. DMEM supple-
mented with 20% FCS and GVA antibiotics was used forcell culture. The infected HeLa and HEp-2 cells were har-
vested at 48 and 72 h after infection, respectively, and
stored at −80°C. The cell suspensions were disrupted by
freezing–thawing and centrifugation at 400 × g to remove
cell debris. The bacteria were collected by centrifugation
at 1000 × g and resuspended in sucrose–phosphate–
glutamic acid buffer (0.2-M sucrose, 3.8-mM KH2PO4,
6.7-mM Na2HPO4 and 5-mM L-glutamic acid). The
bacteria were stored at −80°C until use. The number of bac-
terial infectious particles equal to EBs was determined by
inclusion-forming unit (IFU) assay [27] as described below.
Both bacterial genomic DNAs were extracted with High
Pure PCR Template Preparation Kit (Roche, Indianapolis,
IN, USA) and used as a template DNA for copN genes
cloning.
Construction of recombinant CopNs
Full-length copN genes [CpcopN: C. pneumoniae TW183,
CpB0334 (NC_005043.1); CtcopN: C. trachomatis UW-3/
CX serovar D, CT_089 (NC_000117.1)] were amplified
from each of the genomic DNA templates. The amplified
DNA products were cloned to the downstream of gluta-
thione S-transferase (GST) gene region into pGEX-6P-1
plasmid (GE Healthcare Bio-Sciences AB, Uppsala,
Sweden). pGEX-6P-1 plasmid was kindly provided by I.
Hirai, University of the Ryukyus (Okinawa, Japan). GST-
fused recombinant proteins were finally expressed in
Escherichia coli BL21 (DE3) in Luria–Bertani medium
with 0.1-mM isopropyl-1-thio-β-D-galactopyranoside for
4 h at 37°C. The bacteria were collected by centrifugation
and then lysed chemically using bacterial protein extrac-
tion reagent (Thermo Fisher Scientific, Waltham, MA,
USA). After centrifugation to remove bacterial debris,
GST-fusion proteins were prepared from the supernatant
by using glutathione–agarose beads (Thermo Fisher
Scientific) and the protein concentrations were determined
using the Bradford assay. The solutions were adequately
dispensed and stored at −80°C until use.
Pull-down assay with mass spectrometry (MS)
GST-fusion proteins were mixed with the soluble frac-
tion obtained from HEp-2 cells, and then incubated
for 4–12 h at 4°C in cell lysis buffer containing 40-mM
Tris–HCl (pH 7.5), 150-mM sodium chloride, 0.5%
Triton-X-100, and 1% protease inhibitor cocktail (Nacalai
Tesque, Kyoto, Japan) in the presence of glutathione–
agarose beads (Thermo Fisher Scientific). After washing
with 50-mM Tris–HCl (pH 6.8), the captured proteins on
beads were eluted with sample buffer for SDS-PAGE. Pro-
tein profiles into the eluted solutions were visualized by
SDS-PAGE with Coomassie brilliant blue staining, and the
specific band presumably captured by CopN was cut out
from the gel, and then used for nano-liquid chromatog-
raphy tandem MS (nano-LC-MS/MS) analysis (Japan Bio
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by the Japan Bio Services.
RNA extraction and conventional or quantitative
reverse-transcription polymerase chain reaction (qRT-PCR)
Total RNA was extracted from chlamydia-infected or
uninfected HEp-2 cells using High Pure RNA Isolation Kit
(Roche) according to the manufacturer’s protocol. Reverse
transcription of 500-ng total RNA was performed with
ReverTraAce qPCR RT Master Mix (Toyobo, Osaka,
Japan). Resultant cDNAs were used for PCR amplification
with the following primers: (gapdh) (forward 5′-AAC
GGG AAG CTC ACT GGC ATG-3′; reverse 5′-TCC
ACC ACC CTG TTG CTG TAG-3′) [28], aldolase A
(forward 5′-CGC AGA AGG GGT CCT GGT GA-3′; re-
verse 5′-CAG CTC CTT CTT CTG CTC CGG GGT-3′)
[29], enolase (forward 5′-GAG CTC CGG GAC AAT
GAT AA-3′; reverse 5′-CTG TTC CA TCC ATC TCG
ATC-3′) [30], β-actin (forward 5′-GAC CAC ACC TTC
TAC AAT GAG-3′; reverse 5′-GCA TAC CCC TCG
TAG ATG GG-3′) [31] and chlamydial 16S rRNA (for-
ward 5′-CGG CGT GGA TGA GGC AT-3′; reverse 5′-
TCA GTC CCA GTG TTG GC-3′) [32]. PCR conditions
were 95°C for 10 min, followed by 25–40 cycles of 95°C
for 30 s, 55 or 60°C for 30 s and 72°C for 45 s, followed by
72°C for 10 min. PCR products were visualized on 2%
agarose gels with ethidium bromide. For qRT-PCR, result-
ant cDNAs were also amplified by SYBR Green Realtime
PCR Master Mix (Toyobo) using the above primer sets. The
transcript amount of target gene products was expressed
as a ratio to that of β-actin.
Establishment of aldolase A knockdown cells and
chlamydial infection
Transient aldolase A knockdown HEp-2 cells were estab-
lished by 24-h transfection of cells with siRNA as follows:
passenger strand, 5′-CCG AGA ACA CCG AGG AGA A
dTdT-3′; guide strand, 5′-UUC UCC UCG GUG UUC
UCG G dTdT-3′. Non-targeting scramble RNA was also
constructed by Hokkaido System Science (Sapporo, Japan)
as follows: passenger strand, 5′-UUC UCC GAA CGU
GUC ACG UdTdT-3′; guide strand, 5′-ACG UGA CAC
GUU CGG AGG AGA AdTdT-3′. Transfection of siRNA
(or scramble RNA) to cells was performed with a transfec-
tion reagent, Multifectam (Promega, Madison, WI, USA),
according to the manufacturer’s protocol as below. Trans-
fection complexes were prepared by incubating 20 μL of
the prepared siRNA [or scramble RNA (1.0 pmol/μl)] with
10-μl Multifectam for 30 min at room temperature. After
incubation, total transfection complexes were added to
HEp-2 cells adjusted to 1 × 105 cells, and then incubated
for 24 h at 37°C in 5% CO2. Expression of aldolase A was
confirmed by Western blotting. At 24 h after transfection,
HEp-2 cells were infected with chlamydiae at MOI 5 bycentrifugation at 400 × g for 1 h. After washing uninfected
bacteria with DMEM, chlamydia-infected cells were cul-
tured for up to 72 h, and bacterial growth was monitored
by IFU assay and Western blotting.
IFU assay and inclusion images
The number of chlamydial infectious particles (EBs) was
determined by IFU assay by counting chlamydial inclusions
formed in HEp-2 cells using fluorescein-isothiocyanate-
conjugated monoclonal anti-Chlamydia antibody specific
for Chlamydia lipopolysaccharide (with Evans Blue) (Denka
Seiken, Tokyo, Japan), as described previously [27]. In some
experiments, the cells were grown on cover glass, and
chlamydial inclusion images were captured using a digital
camera with a fluorescence microscope.
Western blotting
Infected and uninfected cells collected from each culture
were boiled for 5 min in SDS sample buffer containing
2-mercaptoethanol. After boiling, each sample was soni-
cated to remove viscosity. Samples were loaded and sep-
arated by 10% (w/v) SDS-PAGE. Separated proteins were
transferred to polyvinylidene difluoride membranes by
semi-dry electroblotting. The membrane was blocked
with 5% skimmed milk in Tris-buffered saline including
Tween-20 (TBST). After washing the blocked membrane
with TBST, the membrane was incubated with a primary
antibody [mouse anti-GST monoclonal antibody (Nacalai
Tesque), rabbit anti-human aldolase A polyclonal anti-
body (Cell Signaling Technology, Danvers, MA, USA),
mouse anti-α-tubulin monoclonal antibody (Sigma–
Aldrich) and rabbit anti-RpoD polyclonal antibody (pre-
pared by Sigma–Aldrich)] for 1 h at room temperature.
This was followed by a secondary antibody [horseradish
peroxidase (HRP)-conjugated goat anti-mouse IgG and
IgM antibody (Jackson ImmunoResearch, West Grove,
PA, USA) and HRP-conjugated goat anti-rabbit IgG anti-
body (KPL, Gaithersburg, MD, USA)] for 1 h at room
temperature. Labeled proteins were visualized with Pierce
Western Blotting Substrate (Thermo Fisher Scientific).
Statistical analysis
Data were expressed as mean ± standard deviation (SD).
Comparison of data was performed using an unpaired
Student t test. A value of p < 0.05 was considered signifi-
cant. All experiments were repeated at least three times.
Results and discussion
Chlamydiae are obligate intracellular pathogens infecting
various vertebrate cells, including human. To optimize
the intracellular niche for their propagation, chlamydiae
utilize several T3SS effector proteins. Several chlamydial
T3SS effectors including TARP [12], IncA [13] and CopN
[14] have been reported with detailed protein structures,
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manipulate host cells, resulting in successful adaptation.
CopN effector is well conserved among chlamydiae, func-
tioning both as the T3SS plug and a secreted effector pro-
tein [23]. The effector protein is responsible for a centralFigure 1 Sequence similarity between C. pneumoniae and C. trachoma
similarity between C. pneumoniae and C. trachomatis CopNs. Amino acid se
nlm.nih.gov/genome/). C. pneumoniae TW183 CopN, CpB0334 (accession n
(accession number: NC_000117.1). Alignment was constructed by web soft
48% homology as compared with C. trachomatis CopN. Stars highlighte
constructed recombinant GST-fused CopNs. Cpn, C. pneumoniae CopN full len
(GST-CtCopN). GST, GST alone. (C) Representative pull-down images with GST
band captured by GST–CpCopN, but not GST–CtCopN, in the HEp-2 cell lysatrole in chlamydial adaptation to host cells. Recent studies
have elegantly demonstrated that CopN manipulates host
cells, causing mitotic arrest [33], and that CopN interacts
with tubulin, preventing microtubule assembly [23,24].
However, whether the CopN targets tubulin alone remainstis CopNs and representative pull-down images. (A) Sequence
quence data were obtained from NCBI genome site (http://www.ncbi.
umber: NC_005043.1). C. trachomatis UW-3/CX serovar D CopN, CT_089
ware, UniProt (http://www.uniprot.org/). C. pneumoniae CopN had
d gray indicate identical amino acids. (B) Protein expression profiles of
gth (399 aa) (GST-CpCopN). CtD, C. trachomatis CopN full length (421 aa)
-fused chlamydial CopNs in HEp-2 cell lysates. Red arrow shows a specific
es.
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find previously unidentified chlamydial CopN effector tar-
gets in host cells.
C. pneumoniae CopN interacts with human aldolase A
The CopN protein family, which functions as T3SS plug
proteins with effector functions, is strictly conserved
with weak sequence homology to chlamydiae and otherFigure 2 Pull-down assay with MS analysis and Western blotting show
(A) MS data with nano-LC-MS/MS. Bold red amino acid sequences, peptide
a specific aldolase A antibody for elution obtained from pull-down assay w
cell lysates. GST, GST alone. Cpn, GST-fused C. pneumoniae CopN (GST-CpC
aldolase A. Asterisk, fragmented proteins.Gram-negative bacteria [9], and the sequence similarity
of CopNs used for this study was 48% (Figure 1A). To
identify the host proteins that interact with chlamyd-
ial CopN, we performed a pull-down assay with GST-
fused recombinant CopN proteins (C. pneumoniae: GST–
CpCopN, C. trachomatis: GST–CtCopN) and HEp-2 cell
lysates. Coomassie brilliant blue staining revealed that
unrelated contaminants in the recombinant fractionsing that C. pneumoniae CopN interacts with human aldolase A.
matched sequences. (B) Representative Western blotting pattern with
ith GST-fused chlamydial CopNs and HEp-2 cell lysates. Input, HEp- 2
opN). CtD, GST-fused C. trachomatis CopN (GST-CtCopN). Red arrow,
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(Figure 1B). As a result, a specific band with ~40-kDa
molecular size was detected in the eluted pull-down frac-
tion with GST–CpCopN, but not in that with GST–Ctr
CopN or GST alone (Figure 1C, arrowhead). It was a pos-
sible candidate for CopN target molecule, thus, the band
cut out from the gel was analyzed by nano-LC/MS/MS.Figure 3 Changes in chlamydial infectious particle numbers in aldolase
images in knockdown HEp-2 cells. scRNA, scramble RNA transfected cells. ALD
images of inclusions formed in the knockdown HEp-2 cells. Chlamydiae
3 days. Morphological changes in the inclusions were assessed under flu
days after infection. Green, inclusions. (C, D) Changes in chlamydial infectious p
by IFU assay. The IFU numbers were also assessed at the same time as above.
experiments. *p < 0.05 versus value into scRNA-transfected cells. N.S., noAs a result, MS revealed two distinct eukaryotic proteins
to be aldolase A, which is involved in glycolytic metabol-
ism, and lancC-like protein, which is a lanthionine synthe-
tase component (Figure 2A). The peptide hit numbers and
coverage against aldolase A were significantly high com-
pared with those for lancC-like protein (Figure 2A); there-
fore, we concluded that GST–CpCopN target proteinA knockdown cells. (A) Representative aldolase A protein expression
OA, aldolase A targeting siRNA transfected cells. (B) Representative
infected knockdown cells at MOI 5, and were incubated for up to
orescence microscopy at 3 (for C. pneumoniae) or 2 (for C. trachomatis)
article (IFU) numbers in the knockdown cells. Bacterial IFUs were evaluated
Data show mean ± SD obtained from at least three independent
t significant. C. pneumoniae (C). C. trachomatis (D).
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we performed Western blotting with a specific antibody
against human aldolase A in pull-down eluted fractions.
As expected, Western blotting clearly indicated a spe-
cific band reacting with the specific antibody, demon-
strating that the GST-fused CpCopN target molecule
was aldolase A, which is an important enzyme in glycoly-
sis and glyconeogenesis, and affects actin polymerization
via the Wiskott–Aldrich syndrome protein (WASP)/
Arp2/3 pathway [34] (Figure 2B).
To the best of our knowledge, we are the first to show
that chlamydial CopN could capture human aldolase A.
Intriguingly, because no specific protein was seen in the
case of C. trachomatis CopN, this capturing was specific
to C. pneumoniae CopN effector. The exact reason for
specific binding remains unclear, but it is likely associ-
ated with the low amino acid sequence similarity (48%)
between the CopNs. Furthermore, previous work has
indicated that while C. pneumoniae directly secretes CopN
into the host cytosol across the inclusion membrane,Figure 4 Representative images showing chlamydial RpoD protein ex
(A) Representative images showing chlamydial RpoD protein expression in
chlamydiae at MOI 5 were incubated for up to 3 days. RpoD protein expre
against chlamydial RpoD. (B) Kinetic change of chlamydial RpoD protein ex
(for C. trachomatis) days after infection. Band-density values were evaluated
least three independent experiments. N.S., not significant.C. trachomatis CopN is embedded in the inclusion mem-
brane, and is never translocated to the host cell cytosol,
suggesting that the target molecule of C. trachomatis
CopN may be buried in the membrane fraction, without
high solubility [14]. Taken together, the findings imply a
possible different effector target and function between
C. pneumoniae and C. trachomatis CopNs.
Our pull-down system with GST-fused CopN proteins
and cell lysates unfortunately could not capture microtu-
bulin, which is a cytoskeletal fiber, as described previ-
ously [23]. That research group used a gel filtration
assay with microtubulin pelleting required for large
amounts of recombinant proteins [23]; thus, there might
have been a critical difference in detection sensitivity.
Alternatively, the previous study also indicated that, in
contrast to tubulin, C. pneumoniae CopN could not bind
directly to microtubulin [23]; therefore, a possible ex-
planation may be in our pull-down system with whole
cell lysates, which naturally conserves cellular molecular
structures.pression and its kinetic change into aldolase A knockdown cells.
knockdown cells. Aldolase A knockdown cells infected with
ssion was evaluated using Western blotting with a specific antibody
pression in aldolase A knockdown cells at 3 (for C. pneumoniae) or 2
by NIH Image J software. Data show mean ± SD obtained from at
Ishida et al. BMC Microbiology  (2014) 14:330 Page 8 of 10Chlamydial growth is stimulated in aldolase A knockdown
cells
Although it is not clear why chlamydiae should seques-
ter host glycolytic enzymes such as aldolase A into in-
fected cells, it is possible that glycolytic enzymes may be
signaling molecules that sense viral or bacterial infection
in the host cells, and that diminishing the signals may
benefit chlamydial survival in the host cells. To confirm
this hypothesis, we constructed transient aldolase A
knockdown cells using siRNA, and assessed whether chla-
mydial growth could change in these cells. First, successful
silencing of aldolase A was confirmed by western blotting
with a specific antibody against aldolase A (Figure 3A,
upper panel right). Chlamydial growth was carefully moni-
tored in the knockdown cells by observation of inclusion
morphology, bacterial count (EB numbers) with IFU assay,
and western blotting for bacterial RpoD expression. In
contrast to the immunofluorescence staining patterns of
chlamydial inclusions (Figure 3B), the number of C. pneu-
moniae IFUs significantly increased in the knockdown
cells (Figure 3C), and such a tendency to increase bacterial
numbers was also seen in the C. trachomatis-infected
knockdown cells, but with no significance (Figure 3D).Figure 5 Expression of genes encoding glycolytic enzymes including
cells with chlamydial infection. (A) Representative RT-PCR images showin
β-actin in infected HEp-2 cells. C. pneumoniae infected cells at MOI 5 were
changes in glycolytic enzyme gene expression in HEp-2 cells with chlamyd
The values were normalized to that of β-actin. Data show mean ± SD fromFurthermore, changes in expression of RpoD, which is a
core component of RNA polymerase and constitutively
expressed in chlamydiae [34], were monitored using west-
ern blotting with a specific antibody against RpoD. Similar
to IFU assessment data, the expression of RpoD tended to
increase in the knockdown cells with either C. pneumo-
niae or C. trachomatis infection (Figure 4). We concluded
that aldolase A silencing enhanced chlamydial growth. In
addition, we confirmed by trypan blue staining that viabil-
ity of aldolase A knockdown cells was maintained, indicat-
ing that the influence of dead cells was minimal in
chlamydial growth (data not shown).
As mentioned above, the exact reason why sequester-
ing aldolase A is required for stimulating chlamydial
growth in infected HEp-2 cells remains undetermined.
Recent work has shown that multifunctional glycolytic
enzymes including aldolase A have so-called “moonlight
functions” [35,36]. For example, it is well known that al-
dolase A binds to F-actin [37], and this binding step is
important for secondary moonlight functions, such as
vesicle trafficking [37], or cell motility [38]. Furthermore,
aldolase A sequesters WASP and affects WASP/Arp2/3
complex associating with actin remodeling [39,40]. WASP/aldolase A, GAPDH and enolase, and the kinetic changes in HEp-2
g expression of genes encoding aldolase A, chlamydial 16S rRNA and
collected at 24, 48 and 60 h. uninf, uninfected HEp-2 cells. (B) Kinetic
ial infection. The gene expression changes were evaluated by qRT-PCR.
at least three independent experiments. N.S., not significant.
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in turn activate the Arp2/3 complex to create new actin
filaments [41]. More importantly, a recent study has indi-
cated that caspase-1 digestome senses fragmented glyco-
lytic enzymes, including aldolase A, digested in infected
cells, resulting in cell death; a novel host defense system
[42]. Based on these findings, we now speculate that se-
questering aldolase A by CopN may be a survival strategy
of chlamydiae in infected host cells, via preventing host cell
death. Similar to C. pneumoniae, C. trachomatis growth
was stimulated in aldolase A knockdown cells.
Aldolase A gene expression tends to increase in
C. pneumoniae-infected cells
To understand the possible fate of aldolase A seques-
tered by CopN effector in C. pneumoniae-infected cells,
the changes in expression of glycolytic enzyme genes in-
cluding aldolase A, gapdh and enolase were monitored
in parallel using qRT-PCR in infected and uninfected
HEp-2 cells. Chlamydial infection to HEp-2 cells tended
to enhance aldolase A gene expression as compared with
the uninfected cells (Figure 5A). The slight increases in
gapdh and enolase expression were also seen in the in-
fected cells (Figure 5B, middle and right panels). Although
further study is needed to clarify this, there may be a
backup system to recover unexpected damage with abnor-
mal metabolic pathways, occurring by sequestering glyco-
lytic enzymes into host cells. It has been reported that
changes in expression of glycolytic enzymes by bacterial
infections have been shown in Drosophila melanogaster
[43]. This finding presumably supports our hypothesis.
Conclusions
This is believed to be the first study to show the interaction
between C. pneumoniae T3SS effector CopN and human
aldolase A. Although more experiments are needed to re-
veal why CopN should bind to aldolase A, sequestering al-
dolase A may be beneficial to bacterial growth in infected
host cells, contributing to our understand of chlamydial
pathogenesis and complicated host–parasite relationships.
Competing interests
The funders had no role in the study design, data collection or analysis,
decision to publish, or preparation of the manuscript. The authors declare
that no competing interests exist.
Authors’ contributions
KI performed the research and data analysis. KI, JM, YY and HY designed the
experiments. KI and HY wrote the paper. All authors read and approved the
final manuscript.
Acknowledgments
We thank Dr. Itaru Hirai who provided us with a plasmid vector, pGEX-6P-1
plasmid. This study was supported by Grants-in-Aid for Japan Society for
the Promotion Science (JSPS) fellows (12 J03692) and scientific research
from KAKENHI (21590474, 24659194, and 24117501 “Innovation Areas:
Matryoshka-type evolution”).Author details
1Department of Medical Laboratory Science, Faculty of Health Sciences,
Hokkaido University, Sapporo, Hokkaido 060-0812, Japan. 2Research Fellow of
Japan Society for the Promotion of Science, Tokyo 102-0083, Japan.
3Department of Biomedical Informatics, Osaka University Graduate School of
Medicine, Suita, Osaka 565-0871, Japan. 4Japan Science and Technology
Agency/Japan International Cooperation Agency, Science and Technology
Research Partnership for Sustainable Development (JST/JICA, SATREPS),
Osaka, Japan. 5Osaka Prefectural Institute of Public Health, Higashinari-ku,
Osaka 537-0025, Japan.
Received: 26 August 2014 Accepted: 16 December 2014References
1. Blasi F, Tarsia P, Aliberti S: Chlamydophila pneumoniae. Clin Microbiol Infect
2009, 15(1):29–35.
2. Belland RJ, Ouellette SP, Gieffers J, Byrne GI: Chlamydia pneumoniae and
atherosclerosis. Cell Microbiol 2001, 6(2):117–127.
3. Gottlieb SL, Berman SM, Low N: Screening and treatment to prevent
sequelae in women with Chlamydia trachomatis genital infection:
how much do we know? J Infect Dis 2010, 201(Suppl 2):S156–S167.
4. Malik A, Jain S, Rizvi M, Shukla I, Hakim S: Chlamydia trachomatis infection
in women with secondary infertility. Fertil Steril 2009, 91(1):91–95.
5. Hahn DL, Schure A, Patel K, Childs T, Drizik E, Webley W: Chlamydia
pneumoniae-specific IgE is prevalent in asthma and is associated with
disease severity. PLoS One 2012, 7(4):e35945.
6. Abdelrahman YM, Belland RJ: The chlamydial developmental cycle.
FEMS Microbiol Rev 2005, 29(5):949–959.
7. Abromaitis S, Stephens RS: Attachment and entry of Chlamydia have
distinct requirements for host protein disulfide isomerase. PLoS Pathog
2009, 5(4):e1000357.
8. Hybiske K, Stephens RS: Mechanisms of host cell exit by the intracellular
bacterium Chlamydia. Proc Natl Acad Sci U S A 2007, 104(27):11430–11435.
9. Betts-Hampikian HJ, Fields KA: The chlamydial type III secretion
mechanism: revealing cracks in a tough Nut. Front Microbiol 2010, 1:114.
10. Carayol N, Tran Van Nhieu G: Tips and tricks about Shigella invasion of
epithelial cells. Curr Opin Microbiol 2013, 16(1):32–37.
11. van der Heijden J, Finlay BB: Type III effector-mediated processes in
Salmonella infection. Future Microbiol 2012, 7(6):685–703.
12. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, Mead DJ,
Carabeo RA, Hackstadt T: A chlamydial type III translocated protein
is tyrosine-phosphorylated at the site of entry and associated with
recruitment of actin. Proc Natl Acad Sci U S A 2004, 101(27):10166–10171.
13. Subtil A, Parsot C, Dautry-Varsat A: Secretion of predicted Inc proteins of
Chlamydia pneumoniae by a heterologous type III machinery. Mol Microbiol
2001, 39(3):792–800.
14. Fields KA, Hackstadt T: Evidence for the secretion of Chlamydia trachomatis
CopN by a type III secretion mechanism. Mol Microbiol 2000, 38(5):1048–1060.
15. Enninga J, Rosenshine I: Imaging the assembly, structure and activity of
type III secretion systems. Cell Microbiol 2009, 11(10):1462–1470.
16. Botteaux A, Sory MP, Biskri L, Parsot C, Allaoui A: MxiC is secreted by and
controls the substrate specificity of the Shigella flexneri type III secretion
apparatus. Mol Microbiol 2009, 71(2):449–460.
17. Martinez-Argudo I, Blocker AJ: The Shigella T3SS needle transmits a signal
for MxiC release, which controls secretion of effectors. Mol Microbiol
2010, 78(6):1365–1378.
18. Plano GV, Schesser K: The Yersinia pestis type III secretion system:
expression, assembly and role in the evasion of host defenses.
Immunol Res 2013, 57(1–3):237–245.
19. Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, Neyt C, Sory MP,
Stainier I: The virulence plasmid of Yersinia, an antihost genome.
Microbiol Mol Biol Rev 1998, 62(4):1315–1352.
20. Ferracci F, Schubot FD, Waugh DS, Plano GV: Selection and
characterization of Yersinia pestis YopN mutants that constitutively block
Yop secretion. Mol Microbiol 2005, 57(4):970–987.
21. Herrmann M, Schuhmacher A, Mühldorfer I, Melchers K, Prothmann C,
Dammeier S: Identification and characterization of secreted effector
proteins of Chlamydophila pneumoniae TW183. Res Microbiol 2006,
157(6):513–524.
Ishida et al. BMC Microbiology  (2014) 14:330 Page 10 of 1022. Ho TD, Starnbach MN: The Salmonella enterica serovar typhimurium-
encoded type III secretion systems can translocate Chlamydia
trachomatis proteins into the cytosol of host cells. Infect Immun 2005,
73(2):905–911.
23. Archuleta TL, Du Y, English CA, Lory S, Lesser C, Ohi MD, Ohi R, Spiller BW:
The Chlamydia effector chlamydial outer protein N (CopN) sequesters tubulin
and prevents microtubule assembly. J Biol Chem 2011, 286(39):33992–33998.
24. Huang J, Lesser CF, Lory S: The essential role of the CopN protein in
Chlamydia pneumoniae intracellular growth. Nature 2008, 456(7218):112–115.
25. Ishida K, Kubo T, Saeki A, Yamane C, Matsuo J, Yimin, Nakamura S, Hayashi Y,
Kunichika M, Yoshida M, Takahashi K, Hirai I, Yamamoto Y, Shibata K,
Yamaguchi H: Chlamydophila pneumoniae in human immortal Jurkat
cells and primary lymphocytes uncontrolled by interferon-γ. Microbes Infect
2013, 15(3):192–200.
26. Yamazaki T, Matsuo J, Nakamura S, Oguri S, Yamaguchi H: Effect of
Ureaplasma parvum co-incubation on Chlamydia trachomatis maturation
in human epithelial HeLa cells treated with interferon-γ. J Infect Chemother
2014, 20(8):460–464.
27. Kobayashi M, Ishida K, Matsuo J, Nakamura S, Nagasawa A, Motohashi K,
Yao T, Hirai I, Yamamoto Y, Suzuki H, Shimizu C, Matsuno K, Yamaguchi H:
Chlamydophila pneumoniae attachment and infection in low
proteoglycan expressing human lymphoid Jurkat cells. Microb Pathog
2011, 51(3):209–216.
28. Gnoatto N, Lotufo RF, Matsuda M, Penna V, Marquezini MV: Expression of
cell-surface heparan sulfate proteoglycans in human cyclosporin-induced
gingival overgrowth. J Periodontal Res 2007, 42(6):553–558.
29. Marone M, Mozzetti S, De Ritis D, Pierelli L, Scambia G: Semiquantitative
RT-PCR analysis to assess the expression levels of multiple transcripts
from the same sample. Biol Proced Online 2001, 3:19–25.
30. Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M,
Tokuhisa Y, Sakamoto K, Takashima M, Tamesa T, Oka M: Glycolysis module
activated by hypoxia-inducible factor 1alpha is related to the aggressive
phenotype of hepatocellular carcinoma. Int J Oncol 2008, 33(4):725–731.
31. Kim SH, Kim KH, Yoo BC, Ku JL: Induction of LGR5 by H2O2 treatment is
associated with cell proliferation via the JNK signaling pathway in colon
cancer cells. Int J Oncol 2012, 41(5):1744–1750.
32. Everett KD, Bush RM, Andersen AA: Emended description of the order
Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae
fam. nov., each containing one monotypic genus, revised taxonomy of
the family Chlamydiaceae, including a new genus and five new species,
and standards for the identification of organisms. Int J Syst Bacteriol 1999,
Pt 2:415–440.
33. Nawrotek A, Guimarães BG, Velours C, Subtil A, Knossow M, Gigant B:
Biochemical and Structural Insights into Microtubule Perturbation by
CopN from Chlamydia pneumoniae. J Biol Chem 2014, pii:jbc.M114.568436.
34. Saka HA, Thompson JW, Chen YS, Kumar Y, Dubois LG, Moseley MA,
Valdivia RH: Quantitative proteomics reveals metabolic and pathogenic
properties of Chlamydia trachomatis developmental forms. Mol Microbiol
2011, 82(5):1185–1203.
35. Wang J, Morris AJ, Tolan DR, Pagliaro L: The molecular nature of the
F-actin binding activity of aldolase revealed with site-directed mutants.
J Biol Chem 1996, 271(12):6861–6865.
36. O'Reilly G, Clarke F: Identification of an actin binding region in aldolase.
FEBS Lett 1993, 321(1):69–72.
37. Merkulova M, Hurtado-Lorenzo A, Hosokawa H, Zhuang Z, Brown D, Ausiello DA,
Marshansky V: Aldolase directly interacts with ARNO and modulates
cell morphology and acidic vesicle distribution. Am J Physiol Cell
Physiol 2011, 300(6):C1442–C1455.
38. Du S, Guan Z, Hao L, Song Y, Wang L, Gong L, Liu L, Qi X, Hou Z, Shao S:
Fructose-bisphosphate aldolase a is a potential metastasis-associated
marker of lung squamous cell carcinoma and promotes lung cell
tumorigenesis and migration. PLoS One 2014, 9(1):e85804.
39. Ritterson Lew C, Tolan DR: Aldolase sequesters WASP and affects WASP/
Arp2/3-stimulated actin dynamics. J Cell Biochem 2013, 114(8):1928–1939.
40. Buscaglia CA, Penesetti D, Tao M, Nussenzweig V: Characterization of an
aldolase-binding site in the Wiskott-Aldrich syndrome protein. J Biol
Chem 2006, 281(3):1324–1331.41. Pollard TD: The cytoskeleton, cellular motility and the reductionist
agenda. Nature 2003, 422(6933):741–745.
42. Shao W, Yeretssian G, Doiron K, Hussain SN, Saleh M: The caspase-1
digestome identifies the glycolysis pathway as a target during infection
and septic shock. J Biol Chem 2007, 282(50):36321–36329.
43. Chambers MC, Song KH, Schneider DS: Listeria monocytogenes infection
causes metabolic shifts in Drosophila melanogaster. PLoS One 2012,
7(12):e50679.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
